Literature DB >> 31956932

Link of ocular pseudoexfoliation syndrome and vascular system changes: results from 10-year follow-up study.

Ugnė Rumelaitienė1, Dalia Žaliūnienė2, Martynas Špečkauskas2, Abdonas Tamošiūnas3, Ričardas Radišauskas3,4, Emilija Jusevičiūtė2, Vidas Vainauskas2, Gailutė Bernotienė3.   

Abstract

PURPOSE: To examine the 10-year incidence of the pseudoexfoliation syndrome (PEX) in adults in a population-based follow-up study, to determine its link with vascular diseases, and to identify possible risk factors of the PEX.
METHODS: The baseline examination was performed in 2006 on a random sample of 1033 participants from Kaunas city (Lithuania) population. In 2016, a follow-up study of 686 participants who returned for the examination was conducted. The respondents filled out a questionnaire, an ophthalmological examination was performed, and the presence of vascular diseases was determined by the anamnesis and electrocardiogram evaluation data. Binary univariate and multivariate logistic regression analyses were conducted with the PEX and vascular diseases as predictors, controlling for age. Odds ratios (OR) and 95% confidence intervals of OR were calculated for the risk of new PEX cases.
RESULTS: During 10 years, the prevalence of the PEX in the study population increased from 10.3 to 34.2%. The rates of ischemic heart disease (IHD) and IHD combined with stroke were significantly higher in the PEX subjects than in the non-PEX subjects. The risk of the PEX among persons with IHD was, on the average, by 1.5-fold higher, and among those with IHD and stroke, on the average, by 1.6-fold higher as compared to persons without the aforementioned pathologies (accordingly, p = 0.014 and p = 0.010).
CONCLUSION: The prevalence of the PEX increased significantly with age. The risk of the PEX was significantly higher among persons with IHD and even higher among persons with IHD and stroke. In the future, a greater understanding of the cardiovascular, metabolic, and environmental components associated with the PEX may lead to more specific lifestyle-related preventive strategies to decrease the disease burden.

Entities:  

Keywords:  Arterial hypertension; Cardiovascular diseases; Ischemic heart disease; Prevalence; Pseudoexfoliation syndrome; Stroke

Mesh:

Year:  2020        PMID: 31956932     DOI: 10.1007/s10792-019-01262-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  34 in total

1.  The prevalence of exfoliation syndrome in Turkey.

Authors:  Raşit Kılıç; Naim Karagöz; Abdi Bahadır Çetin; Yasin Çakmak; Hafize Sezer; Yusuf Özay; Sebile Üstün Çomçalı; Ayhan Dursun
Journal:  Acta Ophthalmol       Date:  2015-10-28       Impact factor: 3.761

2.  Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey.

Authors:  Nilgun Yildirim; Erdogan Yasar; Huseyin Gursoy; Ertugrul Colak
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

3.  Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up.

Authors:  Siv Aström; Hans Stenlund; Christina Lindén
Journal:  Acta Ophthalmol Scand       Date:  2007-11-06

4.  Association of pseudoexfoliation syndrome with increased vascular risk.

Authors:  P Mitchell; J J Wang; W Smith
Journal:  Am J Ophthalmol       Date:  1997-11       Impact factor: 5.258

5.  Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study.

Authors:  M R Praveen; S K Shah; A R Vasavada; R P Diwan; S M Shah; B R Zumkhawala; R Thomas
Journal:  Eye (Lond)       Date:  2010-12-03       Impact factor: 3.775

6.  Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension and diabetes mellitus.

Authors:  Martynas Spečkauskas; Abdonas Tamošiūnas; Vytautas Jašinskas
Journal:  Acta Ophthalmol       Date:  2012-05-02       Impact factor: 3.761

7.  Plasma homocysteine is elevated in patients with exfoliation syndrome.

Authors:  Roberto M Vessani; Robert Ritch; Jeffrey M Liebmann; Mark Jofe
Journal:  Am J Ophthalmol       Date:  2003-07       Impact factor: 5.258

Review 8.  Is exfoliation syndrome a sign of systemic vascular disease?

Authors:  Ahti Tarkkanen
Journal:  Acta Ophthalmol       Date:  2008-12       Impact factor: 3.761

Review 9.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

Review 10.  Ocular pseudoexfoliation syndrome and vascular disease: a systematic review and meta-analysis.

Authors:  Wei Wang; Miao He; Minwen Zhou; Xiulan Zhang
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more
  4 in total

1.  Exploring association between pseudoexfoliation syndrome and ocular aging.

Authors:  Ugne Rumelaitiene; Martynas Speckauskas; Abdonas Tamosiunas; Ricardas Radisauskas; Tunde Peto; Morten Bøgelund Larsen; Dalia Zaliūniene
Journal:  Int Ophthalmol       Date:  2022-09-21       Impact factor: 2.029

2.  Electrodiagnostic signs of carpal tunnel syndrome in ocular pseudoexfoliation syndrome.

Authors:  Mansoor Shahriari; Afshin Karimzadeh; Hadi Esmaily; Saman Rezanejad; Homayoun Nikkhah; Maryam Yadgari; Asma Pourhoseingholi
Journal:  Int Ophthalmol       Date:  2022-04-27       Impact factor: 2.029

3.  Prediagnostic Plasma Metabolomics and the Risk of Exfoliation Glaucoma.

Authors:  Jae H Kang; Oana Zeleznik; Lisa Frueh; Jessica Lasky-Su; A Heather Eliassen; Clary Clish; Bernard A Rosner; Louis R Pasquale; Janey L Wiggs
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-08-02       Impact factor: 4.925

Review 4.  A Case-Cohort Study of Exfoliation Risk Factors and Literature Review.

Authors:  Ahmad M Mansour; Anastasios G P Konstas; Hana A Mansour; Abdul R Charbaji; Khalil M El Jawhari
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.